Greenville Health System Cancer Institute-Laurens

Clinton, South Carolina 29325

0 studies enrolling now · 6 studies all time

What they study most

ATM Gene Mutation, ATR Gene Mutation, BARD1 Gene Mutation, BRCA1 Gene Mutation, BRCA2 Gene Mutation, BRIP1 Gene Mutation, Brain Metastases, CHEK1 Gene Mutation, CHEK2 Gene Mutation, Cognitive Impairment, Colorectal Cancer, FANCA Gene Mutation

Studies at this site

• Enzalutamide for Patients With Androgen Receptor Positive Salivary Cancers — Running, not enrolling
• PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery — Status unconfirmed
• Low-Dose Ibuprofen in Improving Cognitive Impairment in Patients With Cancer — Completed
• Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer — Completed
• Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radionecrosis After Radiosurgery for Brain Metastases — Stopped early
• Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer — Completed